Bruce W. Surber

1.6k total citations
36 papers, 1.2k citations indexed

About

Bruce W. Surber is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Bruce W. Surber has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Organic Chemistry and 5 papers in Pharmacology. Recurrent topics in Bruce W. Surber's work include Receptor Mechanisms and Signaling (9 papers), Mast cells and histamine (5 papers) and Analytical Chemistry and Chromatography (4 papers). Bruce W. Surber is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Mast cells and histamine (5 papers) and Analytical Chemistry and Chromatography (4 papers). Bruce W. Surber collaborates with scholars based in United States, United Kingdom and Switzerland. Bruce W. Surber's co-authors include Peter J. Stang, Samuel Thomas, A. David Rodrigues, Ellen Roberts, Ye Yao, John T. Uchic, Walter S. Trahanovsky, Albert G. Anderson, Alex Buko and Dale J. Kempf and has published in prestigious journals such as Journal of the American Chemical Society, Analytical Biochemistry and Clinical Cancer Research.

In The Last Decade

Bruce W. Surber

36 papers receiving 1.1k citations

Peers

Bruce W. Surber

ONCOL

PHARM

Sander G. Mills United States

Emil Pop United States

Richard Svensson Sweden

Rita Scarpelli Italy

Randall R. Miller United States

Joseph A. Kozlowski United States

William D. Flitter United Kingdom

Albert Jaxa‐Chamiec United Kingdom

Bernard R. Neustadt United States

Hassan H. Farag Egypt

Sander G. Mills United States

Bruce W. Surber

1.2k ×3.4

1.2k ×4.8

304 ×1.3

ONCOL

88 ×0.4

PHARM

100 ×0.5

Citations per year, relative to Bruce W. Surber Bruce W. Surber (= 1×) peers Sander G. Mills

Countries citing papers authored by Bruce W. Surber

Since Specialization

Citations

This map shows the geographic impact of Bruce W. Surber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce W. Surber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce W. Surber more than expected).

Fields of papers citing papers by Bruce W. Surber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce W. Surber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce W. Surber. The network helps show where Bruce W. Surber may publish in the future.

Co-authorship network of co-authors of Bruce W. Surber

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce W. Surber. A scholar is included among the top collaborators of Bruce W. Surber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce W. Surber. Bruce W. Surber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Surber, Bruce W., et al.. (2021). Synthesis of [H‐3]‐ and [C‐14]‐labeled elagolix. Journal of Labelled Compounds and Radiopharmaceuticals. 64(7). 254–261. 4 indexed citations

Shen, Jie, Michael D. Serby, Bruce W. Surber, et al.. (2016). Metabolism and Disposition of Pan-Genotypic Inhibitor of Hepatitis C Virus NS5A Ombitasvir in Humans. Drug Metabolism and Disposition. 44(8). 1148–1157. 16 indexed citations

Lee, Anthony, David W. A. Beno, Xiaolin Zhang, et al.. (2015). A 14C-leucine absorption, distribution, metabolism and excretion (ADME) study in adult Sprague–Dawley rat reveals β-hydroxy-β-methylbutyrate as a metabolite. Amino Acids. 47(5). 917–924. 15 indexed citations

Liu, Xuesong, Yan Shi, David Maag, et al.. (2011). Iniparib Nonselectively Modifies Cysteine-Containing Proteins in Tumor Cells and Is Not a Bona Fide PARP Inhibitor. Clinical Cancer Research. 18(2). 510–523. 139 indexed citations

Milicic, Ivan, Joy Bauch, Bruce W. Surber, et al.. (2009). Use of the H₃receptor antagonist radioligand [³H]‐A‐349821 to revealin vivoreceptor occupancy of cognition enhancing H₃receptor antagonists. British Journal of Pharmacology. 157(1). 139–149. 16 indexed citations

Donnelly‐Roberts, Diana L., Marian T. Namovic, Bruce W. Surber, et al.. (2008). [3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors. Neuropharmacology. 56(1). 223–229. 96 indexed citations

Bianchi, Bruce R., Rachid El Kouhen, Torben R. Neelands, et al.. (2007). [3H]A-778317 [1-((R)-5-tert-Butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a Novel, Stereoselective, High-Affinity Antagonist Is a Useful Radioligand for the Human Transient Receptor Potential Vanilloid-1 (TRPV1) Receptor. Journal of Pharmacology and Experimental Therapeutics. 323(1). 285–293. 12 indexed citations

Anderson, David J., William H. Bunnelle, Bruce W. Surber, et al.. (2007). [3H]A-585539 [(1 S,4 S)-2,2-Dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a Novel High-Affinity α7 Neuronal Nicotinic Receptor Agonist: Radioligand Binding Characterization to Rat and Human Brain. Journal of Pharmacology and Experimental Therapeutics. 324(1). 179–187. 46 indexed citations

Witte, David G., Betty Yao, Thomas R. Miller, et al.. (2006). Detection of multiple H₃receptor affinity states utilizing [³H]A‐349821, a novel, selective, non‐imidazole histamine H₃receptor inverse agonist radioligand. British Journal of Pharmacology. 148(5). 657–670. 23 indexed citations

10.

Yao, B. B., David G. Witte, Ted R. Miller, et al.. (2005). Use of an inverse agonist radioligand [3H]A-317920 reveals distinct pharmacological profiles of the rat histamine H3 receptor. Neuropharmacology. 50(4). 468–478. 9 indexed citations

11.

Yao, B. B., David G. Witte, Tracy L. Carr, et al.. (2005). Use of novel, non-imidazole inverse agonist radioligands to define histamine H3 receptor pharmacology. Inflammation Research. 54(S1). S46–S47. 1 indexed citations

12.

Moreland, Robert B., Marc A. Terranova, Renjie Chang, et al.. (2004). [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor. European Journal of Pharmacology. 497(2). 147–154. 12 indexed citations

13.

Shankar, V., et al.. (2001). In Vitro Metabolism of 19-Nor-1α,25-(OH)2D2 in Cultured Cell Lines: Inducible Synthesis of Lipid- and Water-Soluble Metabolites. Archives of Biochemistry and Biophysics. 387(2). 297–306. 9 indexed citations

14.

Warrior, Usha, X. Grace Chiou, Michael P. Sheets, et al.. (1999). Development of a p38 Kinase Binding Assay for High Throughput Screening. SLAS DISCOVERY. 4(3). 129–135. 7 indexed citations

15.

Kumar, Gondi, Ellen Roberts, Dean Hickman, et al.. (1999). Potent Inhibition of the Cytochrome P-450 3A-Mediated Human Liver Microsomal Metabolism of a Novel HIV Protease Inhibitor by Ritonavir: A Positive Drug-Drug Interaction. Drug Metabolism and Disposition. 27(8). 902–908. 133 indexed citations

16.

Faghih, Ramin, et al.. (1996). 3H-labeling of prokinetic motilide ABT-229 for biodistribution and metabolism studies. Journal of Labelled Compounds and Radiopharmaceuticals. 38(7). 687–692. 2 indexed citations

17.

Surber, Bruce W., Samuel Thomas, Andrew S. Tasker, et al.. (1994). [3H]A-81988, a potent, selective, competitive antagonist radioligand for angiotensin AT1 receptors. European Journal of Pharmacology Molecular Pharmacology. 267(1). 49–54. 3 indexed citations

18.

Rodrigues, A. David, Michael Kukulka, Bruce W. Surber, et al.. (1994). Measurement of Liver Microsomal Cytochrome P450 (CYP2D6) Activity Using [O-methyl-14C] Dextromethorphan. Analytical Biochemistry. 219(2). 309–320. 58 indexed citations

19.

Surber, Bruce W., et al.. (1991). Preparative separation and analysis of the enantiomers of [3H]Abbott-69992, an HIV anti-infective nucleoside, by ligand-exchange high-performance liquid chromatography. Journal of Chromatography A. 586(2). 265–270. 12 indexed citations

20.

Surber, Bruce W., et al.. (1991). Synthesis of [¹⁴C]A‐62514, a radiolabelled derivative of erythromycin a, via [2‐¹⁴C]N, N‐dimethylethylenediamine. Journal of Labelled Compounds and Radiopharmaceuticals. 29(1). 23–27. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact